Curaleaf Holdings (CURLF) Interest Coverage Ratio Growth (1y) (2020 - 2026)
Curaleaf Holdings (CURLF) Interest Coverage Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Curaleaf Holdings | 2.50 Bn | 2.40 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -96.56% |
| Dec 31, 2025 | -99.80% |
| Dec 31, 2024 | 2,840,204.39% |
| Sep 30, 2024 | -89.19% |
| Dec 31, 2023 | 100.01% |
| Sep 30, 2023 | 95.92% |
| Sep 30, 2022 | 560.78% |
| Sep 30, 2021 | -18.92% |
| Jun 30, 2021 | 2,460.11% |
| Mar 31, 2021 | 18,065.76% |
| Dec 31, 2020 | 316.62% |